Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News

Cytori's Cardiovascular And Chronic Liver Disease Cell Therapy Clinical Studies Approved In Japan 



October 25, 2012 - (Cytori) - "Cytori Therapeutics (NASDAQ: CYTX) today announced two independent investigator-sponsored and funded cell therapy clinical studies in Japan have been approved by the Ministry of Health, Labor and Welfareunder the Guidelines on Clinical Research Using Human Stem Cells. One study will investigate the use of Cytori’s cell therapy as a treatment for ischemic heart failure and the other as a treatment for cirrhosis of the liver."  Read Full Article


Posted on 13-Nov-12 by Gallerno, Jacob
Tags: Science and Industry News
Trackback Url  |  Link to this post | Bookmark this post with: